Acquired haemophilia

Authors

  • Ana Cabral Serviço de Medicina I do Hospital de Egas Moniz, Lisboa
  • Teresa Romão Serviço de Medicina I do Hospital de Egas Moniz, Lisboa
  • J. A. Monteiro Serviço de Medicina I do Hospital de Egas Moniz, Lisboa
  • L. Sousa Uva Serviço de Medicina I do Hospital de Egas Moniz, Lisboa

Keywords:

acquired haemophilia, factor VIII inhibitor, haemorrhagic diathesis

Abstract

Spontaneous development of autoantibodies against factor VIII protein in a nonhaemophilic is a rare but significant clinical occurrence that frequently is associated with life-threatening haemorhagic complications.

Acquired haemophilia has been associated with several disorders, namely neoplastic diseases, but often no cause is found.

The authors present a short revision of this condition, based upon a case report of a 73 year old female admitted with a severe haemorrha­gic diathesis.

Downloads

Download data is not yet available.

References

Green D. Lechner K. A survey of 215 non-hemophilic patient with inhibitors to factor Vlll.Thromh Haemost 1981;45:200- 20.1.

Lusher JM. Acquired inhihitors to factor VIII in non-hemophilic patients. ln: Craij Kessler, ed,. Acquired Hemophilia 2nd ed. Princeton. Excerpta Medica Inc. 1995:1-8.

Kessler CM: An introduction to factor VIII inhibitors: the detec­tion and quantitation. AmJ Med 199l;vol 91.suppl 5A: 1-5.

Green D. Acquired Factor VIII Inhibitors and immunosuppressi­on of autoantibodies. ln: Craij Kessler, eds. Acquired Hemo­ philia 2nd ed. Princeton.Excerpta Medica lnc. l995;25-40.

Hoyer LW, Scandella D: Factor VIII inhibitors :structure and func­tion in autoantibody and hemophilia A patient. Seminars in Hematology 1994; 2(2) 4:1-5.

Hltin MB: Acquired inhihitors in malignant and nonmalignant disease states. Am J Med 1991:vol 91.suppl 5A:9-13.

Garvey MH: lncidence and management of patients with acqui­red factor VIII inhibitors: The practical experience of a tertiary care Hospital. ln: Craij Kessler, eds. Acquired Hemophi­lia 2nd ed. Princeton. Excerpta Medica lnc. 1995;91-111.

Ludbm CA, Morrison AE, Kessler C. Treatment of acquired he­mophilia. Seminars in Hematology 1994; 2(2) 4:16-19.

Kasper CK. Lahoratory diagnosis of factor VIII inhibitors. ln: Craij Kessler, eds. Acquired Hemophilia 2nd ed. Princeton. Ex­cerpta Medica lnc. 1995:9-23.

Green D: Cytotoxic suppression of acquired factor VIIl:C inhi­bitors. Am.J Med 1991; 91(suppl 5A) 14-19.

Kasper CK. Raising factor VIII leveis in patients with acquired factor VIII inhibitors. ln: Craij Kessler, ecb. Acquired Hemo­philia 2nd ed. Princeton. Excerpta Medica lnc. 1995;41-69.

Kernoff PBA. Rationale and evolution of therapy with porcine factor VIII:C. Am J Med 1991;9l(suppl 5A):20-22.

Kernoff PBA. Thomas ND, Lilley PA et ai. Clinicai experience with polyelectrolyte-fractionated porcine factor VIII concen­trate in the treatment of hemophiliacs with antibodies to fac­tor VIII. Blood 1984; 63:31-41.

Hay CRM, Bolton-Maggs P: Porcine factor VIII in the manage­ment of patients with factor VIII inhihitors. Transfusion Med Rev 1991; vol V(2):145-151.

Kessler CM. The treatment of acquired factor VIII inhibitors: Worldwide experience with porcine factor VIII. ln: Craij Kes­sler, eds. Acquired Hemophilia 2nd ed. Princeton. Excerpta Medica Inc. 1995;71-89.

Negrier C. The use of porcine factor VIII in France. Seminars in Hematology 1994; 2 (2) 4:29-32.

Kessler CM. Factor VIII inhihitors-an algorithmic approach to treatment. Seminars in Hematology 1994; 2(2) 4:33-36.

Lusher JM. Use of factor VIII bypassing agents to control blee­ding in patients with acquired factor VIII inhib itors. ln: Craij Kessler, eds. Acquired Hemophilia 2nd ed. Princeton. Ex­cerpta Medica Inc. 1995; 115-129.

Lusher JM. l'erspectives on the use of factor IX complex conentrates in the treatment of bleeding in persons with acqui­red factor VIII inhibition. Am.J Med 1991;91Csuppl 5A):30-34.

Schwartz RS, Gabriel DA, Aledort LM et ai. A prospective study of treatment of acquired (autoimmune) factor VIII inhibi­tors with intravenous gammaglobulin. Blood 1995; 86:797- 804.

Sultan Y, Maisonneuve P, Kazatchkine MD, Nydegger UE: Anti­ idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gam­maglohulin. Lancet 1984; 2:765-768.

Sultan Y, Kazatchkine MD e al. Intravenous immunoglohulin in the treatment of spontaneously acquired factor VIII:C inhi­bitors. Am J Med 1991;91(suppl 5A):35-39.

Sultan Y, Kazatchkine et al. The use of immunoglobulins in the treatment of factor VIII inhibitors. Seminars in Hematology 1994;2(2) 4:65-66.

Green D. lmmunosuppression of patients with acquired factor VIII inhibitors. Seminars in Hematology 1994;2(2) 4:60-61.

Lian ECY, Larcada AF, Chiu AYZ. Combination immunisuppres­sive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann lntern Med 1989; 110: 774-778.

Kasper CK. Algorithm for management of patients with acqui­ red hemophilia. ln: Craij Kessler, eds. Acquired Hemophilia 2nd ed. Princeton. Excerpta Medica Inc. 1995;149-153.

Hoyer LW. Future approaches to factor VIII inhibitors therapy. AmJ Med 1991;91(suppl SA):40-44.

Additional Files

Published

1998-03-31

How to Cite

1.
Cabral A, Romão T, Monteiro JA, Sousa Uva L. Acquired haemophilia. RPMI [Internet]. 1998 Mar. 31 [cited 2024 Nov. 23];5(1):53-9. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/2118

Issue

Vol. 5 No. 1 (1998): Janeiro/ Março

Section

Review Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Medicina Interna

Open Access

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)